Browse By Publication: Gynecologic Oncology
|Up a level|
Number of items: 20.
Aghmesheh, Morteza, Edwards, Lyndal, Clarke, Christine, Byth, Karen, Katzenellenbogen, Benita, Russell, Pamela, et al. (2005) Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas. Gynecologic Oncology, 97(1), pp. 16-25.
Baker, Jannah, Janda, Monika, Gebski, Val, Forder, Peta, Hogg, Russell, Manolitsas, Thomas, et al. (2015) Lower preoperative quality of life increases postoperative risk of adverse events in women with endometrial cancer: results from the LACE trial. Gynecologic Oncology, 137(1), pp. 102-105.
Baker, Jannah, Janda, Monika, Graves, Nicholas, Bauer, Judy, Banks, Merrilyn, Garrett, Andrea, et al. (2015) Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial. Gynecologic Oncology, 137(3), pp. 516-522.
Baker, Jannah, Obermair, Andreas, Gebski, Val, & Janda, Monika (2012) Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma : a meta-analysis and systematic review of the literature. Gynecologic Oncology, 125(1), pp. 263-270.
Beesley, Vanessa L., Rowlands, Ingrid J., Hayes, Sandi C., Janda, Monika, O'Rourke, Peter, Marquart, Louise, et al. (2015) Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer. Gynecologic Oncology, 136(1), pp. 87-93.
Belavy, David, Janda, Monika, Baker, Jannah, & Obermair, Andreas (2013) Epidural analgesia is associated with an increased incidence of postoperative complications in patients requiring an abdominal hysterectomy for early stage endometrial cancer. Gynecologic Oncology, 131(2), pp. 423-429.
Brennan, Donal J., Hackethal, Andreas, Metcalf, Alex M., Coward, Jermaine, Ferguson, Kaltin, Oehler, Martin, et al. (2014) Serum HE4 as a prognostic marker in endometrial cancer : a population based study. Gynecologic Oncology, 132(1), pp. 159-165.
Byron, Sara, Gartside, Michael, Wellens, Candice, Goodfellow, Paul, Birrer, Michael, Campbell, Ian, et al. (2010) FGFR2 mutations are rare across histologic subtypes of ovarian cancer. Gynecologic Oncology, 117(1), pp. 125-129.
Drew, A. F., Blick, T. J., Lafleur, M. A., Tim, E. L. M., Robbie, M. J., Rice, G. E., et al. (2004) Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice. Gynecologic Oncology, 95(3), pp. 437-448.
Janda, Monika, Obermair, Andreas, Cella, David, Perrin, Lewis, Nicklin, Jim, Gordon-Ward, Bruce, et al. (2005) The Functional Assessment of Cancer-Vulva: Reliability and Validity. Gynecologic Oncology, 97(2), pp. 568-575.
Jeske, Yvette W., Ali, Shamshad, Byron, Sara A., Gao, Feng, Mannel, Robert S., Ghebre, Rahel G., et al. (2017) FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology. (In Press)
Loessner, D., Quent, V.M.C., Kraemer, J., Weber, E., Hutmacher, D.W., Magdolen, Viktor, et al. (2012) Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance. Gynecologic Oncology, 127(3), pp. 569-578.
Lose, Felicity, Nagle, Christina, O'Mara, Tracy, Batra, Jyotsna, Bolton, Kelly, Song, Honglin, et al. (2010) Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival. Gynecologic Oncology, 119(3), pp. 479-483.
McWhirter, Rebekah E., Thomson, Russell J., Marthick, James R., Rumbold, Alice R., Brown, Matthew A., Taylor-Thomson, Debbie, et al. (2014) Runs of homozygosity and a cluster of vulvar cancer in young Australian Aboriginal women. Gynecologic Oncology, 133(3), pp. 421-426.
Obermair, Andreas, Cheuk, Robyn, Pak, Sok Cheon, Perrin, Lewis, Nicklin, James, Crandon, Alexander J., et al. (2008) Disease-free survival after vaginal vault brachytherapy versus observation for patients with node-negative intermediate-risk endometrial adenocarcinoma. Gynecologic Oncology, 110(3), pp. 280-285.
Obermair, Andreas, Mileshkin, Linda, Merollini, Katharina, Kondalsamy-Chennakesavan, Srinivas, Cheuk, Robyn, Vasey, Paul, et al. (2010) Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma. Gynecologic Oncology, 120(2), pp. 179-184.
Obermair, Andreas, Simunovic, Marko, Isenring, Liz, & Janda, Monika (2017) Nutrition interventions in patients with gynecological cancers requiring surgery. Gynecologic Oncology. (In Press)
Powell, Matthew A., Sill, Michael W., Goodfellow, Paul J., Benbrook, Doris M., Lankes, Heather A., Leslie, Kimberly K., et al. (2014) A phase II trial of brivanib in recurrent or persistent endometrial cancer: An NRG oncology/gynecologic oncology group study. Gynecologic Oncology, 135(1), pp. 38-43.
Rowlands, Ingrid J., Beesley, Vanessa L., Janda, Monika, Hayes, Sandra C., Obermair, Andreas, Quinn, Michael A., et al. (2014) Quality of life of women with lower limb swelling or lymphedema 3-5 years following endometrial cancer. Gynecologic Oncology, 133(2), pp. 314-318.
Sundar, Santhanam, Symonds, R. P., Decatris, Marios P., Kumar, D. M., Osman, A., Vasanthan, S., et al. (2004) Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy. Gynecologic Oncology, 94(2), pp. 502-508.